Top Markets
Coin of the day
Voronoi, Inc. Voronoi, Inc.

Voronoi, Inc.

310210
Pozycja w akcjach #6293
Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a... Voronoi, Inc., founded in 2015 and based in Incheon, South Korea, is a biotechnology company dedicated to the research, development, and identification of small molecule kinase inhibitors. Its extensive product pipeline addresses various medical needs. Key candidates include VRN01, an oral leucine-rich repeat kinase 2 (LRRK2) inhibitor, being developed for glioblastoma multiforme, brain cancer, and pancreatic cancer. Treatments for lung cancer are represented by VRN07, VRN06, and VRN11, while VRN08 and VRN10 are in development for breast cancer. Additionally, VRN02 targets rheumatoid arthritis and atopic dermatitis. The company's pipeline further encompasses VRN04-1 for autoimmune conditions, VRN04-2 for multiple sclerosis and amyotrophic lateral sclerosis (ALS), VRN13 for pulmonary arterial hypertension, and VRN14 for challenging solid tumors.
Cena akcji
$115.48
Kapitalizacja rynkowa
$2.12B
Zmiana (1 dzień)
0.72%
Zmiana (1 rok)
29.38%
Kraj
KR
Handel Voronoi, Inc. (310210)

Kategoria

Historia ceny akcji dla Voronoi, Inc. (310210)
Najwyższa cena zamknięcia: $117.55 dnia 2026-08-01

Najniższa cena zamknięcia: $21.91 dnia 2022-06-01
Historia cen akcji firmy Voronoi, Inc. od 2022 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.57%
2025 181.09%
2024 62.84%
2023 71.45%
2022 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$548.25 40.91%
US
$1.05K 48.60%
NL
$122.63 -12.65%
AU
$142.40 467.33%
US
$765.25 7.19%
CH